跳到正文
原文
Endpoints News· @endpts · X·· 21 天前AI 评分50
AI 导读

诺华CEO Vas Narasimhan表示,因最惠国待遇(MFN)因素,公司在新药上市时可能绕开欧洲政府支付方。相关报道由Endpoints News发布。

正文

Citing MFN, Novartis CEO Vas Narasimhan says the company could bypass European government payers when launching new drugs. https://endpoints.news/novartis-considers-bypassing-european-government-payers-due-to-mfn/?utm_source=Twitter&utm_medium=organic_social&utm_campaign=editorial

来源:Endpoints News · x.com